Our Research Lead examined anonymized platform data from: 5,864 US adults using tirzepatide (Mounjaro or Zepbound) 4,456 US adults using semaglutide (Ozempic or Wegovy) Inclusion criteria: Active GLP-1 therapy with weekly injections Minimum 12-week tracking duration Adherence threshold: 1 injection log and 1 weight entry per week No weight entries outside physiological bounds (30300 kg) or with weekly changes exceeding 5% Primary outcome: Percentage body weight change from baseline, calculated as [(current weight baseline weight) / baseline weight] 100 , where negative values indicate weight loss Data collection period: Data were collected from all available platform records through January 2026, representing naturalistic use patterns without researcher intervention
Unlike traditional weight loss treatments, AOD 9604 targets fat metabolism without causing any negative effects to human growth hormone (HGH) levels
In fact, adult acne continues to affect approximately 15% of the women population
Step 2: If youre starting HRT, earlier is better Research supports initiating MHT in perimenopause, or within 10 years of menopause onset, for the greatest protective effects on heart and brain
1 Gram Per Serving (100 or 245 Servings)
Medical supervision ensures injections are used where science supports them for your safety